Achieving genetic potential for nutrition and growth in cystic fibrosis

Journal of Pediatrics

Volumn 140, Issue 4, 2002, Pages 393-395

  Shepherd, Ross ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; APPETITE STIMULANT; MEGESTROL ACETATE; PANCREAS ENZYME;

ADRENAL SUPPRESSION; CACHEXIA; CALORIC INTAKE; CHILD GROWTH; CLINICAL TRIAL; CYSTIC FIBROSIS; EDITORIAL; ENERGY EXPENDITURE; FEEDING BEHAVIOR; GLUCOSE INTOLERANCE; GROWTH RETARDATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LUNG FUNCTION; MALNUTRITION; NEWBORN SCREENING; NUTRIENT UPTAKE; NUTRITION; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; WEIGHT REDUCTION;

EID: 0036264594     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.123217     Document Type: Article

References (21)

1. Stature as a prognostic factor in cystic fibrosis survival
2. Nutrition intervention for weight gain in cystic fibrosis: A meta analysis
3. Growth hormone improves clinical status in prepubertal children with cystic fibrosis: Results of a randomized controlled trial
4. Effects of megestrol acetate on weight gain, body, composition, and pulmonary function in patients with cystic fibrosis
5. Treatment of anorexia and weight loss with megestrol acetate in patients with cystic fibrosis
6. Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis
7. Neonatal screening for cystic fibrosis
8. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth
9. Nutritional status of children with cystic fibrosis measured by total body potassium as a marker of body cell mass: Lack of sensitivity of anthropometric measures
10. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto
11. Comparison of growth status of patients with cystic fibrosis between the United States and Canada
12. Pancreatic enzyme replacement therapy in cystic fibrosis: Australian guidelines
13. Resting energy expenditure, pulmonary inflammation, and genotype in the early course of cystic fibrosis
14. Growth of human milk-fed and formula-fed infants with cystic fibrosis
15. Dietary intakes of young children with cystic fibrosis: Is there a difference?
16. Descriptive analysis of eating behavior in school-age children with cystic fibrosis and healthy control children
17. Fat gram target to achieve high energy intake in cystic fibrosis
18. Challenges in the dietary treatment of cystic fibrosis related diabetes mellitus
19. Nutritional rehabilitation in cystic fibrosis: A 5 year follow-up study
20. Nutritional rehabilitation in cystic fibrosis: Controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease
21. Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis